Protein kinase C modulates pulmonary endothelial permeability: A paradigm for acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 3 28-3, 2003, Pages

  Siflinger Birnboim, Alma ^a   Johnson, Arnold ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Stratton VA Medical Center   (United States)

Author keywords

Antisense; Edema; Reactive oxygen species; Transcription

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CADHERIN; CALCIUM; CALDESMON; CATENIN; CD31 ANTIGEN; CLAUDIN 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; DIACYLGLYCEROL; HYDROGEN PEROXIDE; INOSITOL 1,4,5 TRISPHOSPHATE; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE SYNTHASE; OCCLUDIN; PHORBOL ESTER; PHOSPHOLIPID; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VIMENTIN;

ENZYME ACTIVITY; FEEDBACK SYSTEM; HUMAN; LEUKOCYTE; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG INJURY; NONHUMAN; PERMEABILITY; PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037372379     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00106.2002     Document Type: Review

References (201)

1. Abate C, Patel L, Rauscher FJ III, Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249: 1157-1249, 1990.
2. phox. J Biol Chem 274: 33644-33653, 1999.
3. Alexander JS, Alexander BC, Eppihimer LA, Goodyear N, Haque R, Davis CP, Kalogeris TJ, Carden DL, Zhu YN, and Kevil CG. Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells. Inflammation 24: 99-113, 2000.
4. Alexander JS, Zhu Y, Elrod JW, Alexander B, Coe L, Kalogeris TJ, and Fuseler J. Reciprocal regulation of endothelial substrate adhesion and barrier function. Microcirculation 8: 389-401, 2001.
5. Allison RC, Marble KT, Hernandez EM, Townsley MI, and Taylor AE. Attenuation of permeability lung injury after phorbol myristate acetate by verapamil and OKY-046. Am Rev Respir Dis 134: 93-100, 1986.
6. Aschner JL, Lennon JM, Fenton JW II, Aschner M, and Malik AB. Enzymatic activity is necessary for thrombin-mediated increase in endothelial permeability. Am J Physiol Lung Cell Mol Physiol 259: L270-L275, 1990.
7. Aschner JL, Lum H, Fletcher PW, and Malik AB. Bradykinin- and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation. J Cell Physiol 173: 387-396, 1997.
8. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, and Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Am J Physiol Lung Cell Mol Physiol 269: L829-L836, 1995.
9. Battaini F. Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol Res 44: 353-361, 2001.
10. Bayraktutan U, Blayney L, and Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 20: 1903-1911, 2000.
11. Bazzoni G and Dejana E. Pores in the sieve and channels in the wall: control of paracellular permeability by junctional proteins in endothelial cells. Microcirculation 8: 143-152, 2001.
12. Bennett CF and Cowsert LM. Application of antisense oligonucleotides for gene functionalization and target validation. Curr Opin Mol Ther 1: 359-371, 1999.
13. Beutler B, Milsark IW, and Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science 229: 869-871, 1985.
14. Bizios R, Lai LC, Cooper JA, Del Vecchio PJ, and Malik AB. Thrombin induced adherence of neutrophils to cultured endothelial monolayers: increased endothelial adhesiveness. J Cell Physiol 134: 275-280, 1988.
15. Blackshear PJ. Approaches to the study of protein kinase C involvement in signal transduction. Am J Med Sci 296: 231-240, 1988.
16. Borregoard N. The human neutrophil function and dysfunction. Eur J Haematol 41: 401-413, 1988.
17. Brandes RP, Koddenbergh G, Gwinner W, Kim D, Kruse HJ, Busse R, and Mugge A. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension 33: 1243-1249, 1999.
18. Brower RG, Ware LB, Berthiaume Y, and Matthay MA. Treatment of ARDS. Chest 120: 1347-1367, 2001.
19. Brus F, van Oeveren W, Okken A, and Oetomo SB. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity. Pediatrics 99: 672-680, 1997.
20. 2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function. Biochem Biophys Res Commun 249: 461-466, 1998.
21. Carley WW, Niedbala MJ, and Gerritsen ME. Isolation, cultivation and partial characterization of microvascular endothelium derived from human lung. Am J Respir Cell Mol Biol 7: 620-630, 1992.
22. Carter CA. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Curr Drug Targets 1: 163-183, 2000.
23. Chen CC, Liau CS, and Lee YT. Tumor necrosis factor-alpha, platelet-activating factor, and hydrogen peroxide activate protein kinase C subtypes alpha and epsilon in human saphenous vein endothelial cells. J Cardiovasc Pharmacol 28: 240-244, 1996.
24. Chiba Y, Ishii Y, Kitamura S, Sugiyama Y. Activation of rho is involved in the mechanism of hydrogen-peroxide-induced lung edema in isolated perfused rabbit lung. Microvasc Res 62: 164-171, 2001.
25. Cho W. Membrane targeting by C1 and C2 domains. J Biol Chem 276: 32407-32410, 2001.
26. Chou CL, Chen HI, Hsu K, Li MH, and Wang D. Dimethylthiourea decreases acute pulmonary edema induced by phorbol myristate acetate in isolated blood-perfused lung of the rat. Proc Natl Sci Counc Repub China B 14: 33-39, 1990.
27. Chu SJ, Chang DM, Wang D, Hsu K, and Chiang CH. Protective effect of lipophilic antioxidants on phorbol-induced acute lung injury in rats. Crit Care Med 29: 819-824, 2001.
28. Clarke H, Soler AP, and Mullin JM. Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci 113: 3187-3196, 2000.
29. Cooper JA, Del Vecchio PJ, Minnear FL, Burhop KE, Selig WM, Garcia JGN, and Malik AB. Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol 62: 1076-1083, 1987.
30. Cote CG, Yu FS, Zulueta JJ, Vosatka RJ, and Hassoun PM. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol Lung Cell Mol Physiol 271: L869-L874, 1996.
31. Coussens L, Parker PJ, Rhee L, Yang-Feng TL, Chen E, Waterfield MD, Francke U, and Ullrich A. Multiple distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 233: 859-866, 1986.
32. Cox JA, Jeng AY, Sharkey NA, Blumberg PM, and Tauber Al. Activation of the human neutrophil nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase by protein kinase C. J Clin Invest 76: 1932-1938, 1985.
33. Curnette JT and Babior BM. Chronic granulomatous disease. Adv Hum Genet 16: 229-297, 1987.
34. Dang PM, Fontayne A, Hakim J, El Benna J, and Perianin A. Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH-oxidase component p47(phox) and participates in formyl-mediated neutrophil respiratory burst. J Immunol 166: 1206-1213, 2001.
35. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, and Yancopoulos GD. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169, 1996.
36. Dejana E, Lampugnani MG, Martinez-Estrada O, and Bazzoni G. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability. Int J Dev Biol 44: 743-748, 2000.
37. Dejana E, Spagnuolo R, and Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86: 308-315, 2001.
38. Del Vecchio PJ, Siflinger-Birnboim A, Belloni PN, Holleran LA, Lum H, and Malik AB. Culture and characterization of pulmonary microvascular endothelial cells. In Vitro Cell Del Biol 28A: 711-715, 1992.
39. DeMichele MA, Moon DG, Fenton JW II, and Minnear FL. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 69: 1599-1606, 1990.
40. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, and Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279: L429-L438, 2000.
41. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
42. Duffy SL and Murphy JT. Colorimetric assay to quantify macromolecule diffusion across endothelial monolayers. Biotechniques 31: 495-501, 2001.
43. Dwyer LD, Miller AC, Parks AL, Jaken S, and Malkinson AM. Calpain-induced downregulation of activated protein kinase C-α affects lung epithelial morphology. Am J Physiol Lung Cell Mol Physiol 266: L569-L576, 1994.
44. Eaton S and Martin G. Clinical developments for treating ARDS. Expert Opin Investig Drugs 11: 37-48, 2002.
45. Ehrhart IC, Orfanos SE, McCloud LL, Sickles DW, Hofman WF, and Catravas JD. Vascular recruitment increases evidence of lung injury. Crit Care Med 27: 120-129, 1999.
46. Eto A, Akita Y, Saido TC, Suziki K, and Kawashima S. The role of the calpain-calpastatin system in thyrotropin releasing hormone-induced selective down-regulation of a protein kinase C isozyme, nPKCε, in rat GH4C1 cells. J Biol Chem 270: 25115-25120, 1995.
47. Fagan KA, McMurtry IF, and Rodman DM. Role of endothelin-1 in lung disease. Respir Res 2: 90-101, 2001.
48. Fan J, Frey RS, Rahman A, and Malik AB. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha-induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 277: 3404-3411, 2002.
49. Fan J, Ye RD, and Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281: L1037-L1050, 2001.
50. Fasano A, Fiorentini C, Donell G, Uzau S, Kaper JB, Margaretten K, Ding X, Guandalini S, Comstock L, and Goldblum SE. Zonula occludens toxin modulates tight junctions through PKC-dependent actin reorganization in vitro. J Clin Invest 96: 710-730, 1995.
51. Fenton JW II, Ofosu FA, Brezniak DV, and Hassouna HI. Thrombin and antithrombotics. Semin Thromb Hemost 24: 87-91, 1998.
52. Ferro T, Neumann P, Gertzberg N, Clements R, and Johnson A. Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol 278: L1107-L1117, 2000.
53. Ferro TJ, Gertzberg N, Selden L, Neumann P, and Johnson A. Endothelial barrier dysfunction and p42 oxidation induced by TNF-α are mediated by nitric oxide. Am J Physiol Lung Cell Mol Physiol 272: L979-L988, 1997.
54. Ferro TJ, Hocking DC, and Johnson A. Tumor necrosis factor-α alters pulmonary vasoreactivity via neutrophil-derived oxidants. Am J Physiol Lung Cell Mol Physiol 265: L462-L471, 1993.
55. Ferro TJ, Parker DM, Commins LM, Phillips PG, and Johnson A. Tumor necrosis factor-α activates pulmonary artery endothelial protein kinase C. Am J Physiol Lung Cell Mol Physiol 264: L7-L14, 1993.
56. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, and Vadas MA. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87: 603-607, 2000.
57. Garcia JG, Davis HW, and Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163: 510- 522, 1995.
58. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J Cell Physiol 156: 541-549, 1993.
59. Garcia JG, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW II, and Malik AB. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 128: 96-104, 1986.
60. Genersch E, Hayess K, Neuenfeld Y, and Haller H. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Rasdependent and -independent pathways. J Cell Sci 113: 4319-4330, 2000.
61. Gimbrone MA Jr and Bivilacqua MP. Vascular endothelium: functional modulation at the blood interface. In: Endothelial Cell Biology In Health and Disease, edited by Simonescu N and Simonescu M. New York: Plenum, 1988, p. 255-273.
62. Goldblum SE, Ding X, and Campbell-Washington J. TNF-α induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol Cell Physiol 264: C894-C905, 1993.
63. Gu Y, Xu YC, Wu RF, Souza RF, Nwariaku FE, and Terada LS. TNF-alpha activates c-Jun amino terminal kinase through p47(phox). Exp Cell Res 272: 62-74, 2002.
64. Gudgeon JR and Martin W. Modulation of arterial endothelial permeability: studies on an in vitro model. Br J Pharmacol 98: 1267-1274, 1989.
65. Hartwig JH, Thelen M, Rosen A, Janmey PA, Nairn AC, and Aderem A. MARCKS is an actin filament cross linking protein regulated by protein kinase C and calcium-calmodulin. Nature 356: 618-622, 1992.
66. Havill AM and Gee MH. Role of interstitium in clearance of alveolar fluid in normal and injured lungs. J Appl Physiol 57: 1-6, 1984.
67. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, and Haller H. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 81: 363-371, 1997.
68. Hennet T, Richter C, and Peterhans E. Tumor necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J 289: 587-592, 1993.
69. Hidaka H, Inagaki M, Kawamoto S, and Sasaki Y. Isoquinolinylsulphonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041, 1989.
70. Hocking DC, Phillips PG, Ferro TJ, and Johnson A. Mechanisms of pulmonary edema induced by tumor necrosis factoralpha. Circ Res 67: 68-77, 1990.
71. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, and Menger MD. The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure. Shock 14: 528-534, 2000.
72. Hohler B, Holzapfel B, and Kummer W. NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol 114: 29-37, 2000.
73. House C and Kemp BE. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238: 1726-1728, 1987.
74. Hu HL, Forsey RJ, Blades TJ, Barratt ME, Parmar P, and Powell JR. Antioxidants may contribute in the fight against ageing: an in vitro model. Mech Ageing Dev 121: 217-230, 2000.
75. Huang Q and Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol Heart Circ Physiol 273: H2442-H2451, 1997.
76. Ignarro LJ, Napoli C, and Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90: 21-28, 2002.
77. Johnson A. PMA-induced pulmonary edema: mechanisms of the vasoactive response. J Appl Physiol 65: 2302-2312, 1988.
78. Johnson A and Ferro TJ. Nitrovasodilator repletion increases TNF-induced pulmonary edema. J Appl Physiol 80: 2151-2155, 1996.
79. Johnson A and Malik AB. Effects of different-size microemboli on lung fluid and protein exchange. J Appl Physiol 51: 461-464, 1981.
80. Johnson A, Phelps DT, and Ferro TJ. Tumor necrosis factor-α decreases pulmonary artery endothelial nitrovasodilator via protein kinase C. Am J Physiol Lung Cell Mol Physiol 267: L318-L325, 1994.
81. 2. Am J Physiol Heart Circ Physiol 256: H1012-H1022, 1989.
82. Johnson J, Meyrick B, Jesmok G, and Brigham KL. Human recombinant tumor necrosis factor-α infusion mimics endotoxemia in sheep. J Appl Physiol 66: 1448-1454, 1989.
83. Johnson JE, Giorgione J, and Newton AC. The C1 and C2 domains of protein kinase C are independent membrane targeting modules, with specificity for phosphatidylserine conferred by the C1 domain. Biochemistry 39: 11360-11369, 2000.
84. Johnson KJ and Ward PA. Acute and progressive lung injury after contact with phorbol myristate acetate. Am J Pathol 107: 29-35, 1982.
85. Kai H, Yoshitake K, Isohama Y, Hamamura I, Takahama K, and Miyata T. Involvement of protein kinase C in mucus secretion by hamster tracheal epithelial cells in culture. Am J Physiol Lung Cell Mol Physiol 267: L526-L530, 1994.
86. Kaslovsky RA, Gibbs L, and Malik AB. Neutrophils from chronic granulomatous disease fail to increase endothelial permeability. Am J Physiol Heart Circ Physiol 261: H1226-H1230, 1991.
87. 2+ and permeability. Am J Physiol Lung Cell Mol Physiol 274: L810-L819, 1998.
88. Kevil CG, Ohno N, Gute DC, Okayama N, Robinson SA, Chaney E, and Alexander JS. Role of cadherin internalization in hydrogen peroxide-mediated endothelial permeability. Free Radic Biol Med 24: 1015-1022, 1998.
89. 2-mediated permeability II: importance of tyrosine phosphatase and kinase activity. Am J Physiol Cell Physiol 281: C1940-C1947, 2001.
90. Kevil CG, Oshima T, and Alexander JS. The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium 8: 107-116, 2001.
91. Kevil CG, Oshima T, Alexander B, Coe LL, and Alexander JS. H202-mediated permeability: role of MAPK and occludin. Am J Physiol Cell Physiol 279: C21-C30, 2000.
92. Kobayashi E, Nakamo H, Morimoto M, and Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553, 1989.
93. Kucharzik T, Walsh SV, Chen J, Parkos CA, and Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159: 2001-2009, 2001.
94. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, and Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987, 2001.
95. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, and Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281: 2042-2045, 1998.
96. Lee WL and Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7: 1-7, 2001.
97. Li H, Oehrlein SA, Wallerath T, Ihrig-Biedert I, Wohlfart P, Ulshofer T, Jessen T, Herget T, Forstermann U, and Kleinert H. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol 53: 630-637 1998.
98. phox in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factoralpha. Circ Res 90: 143-150, 2002.
99. Lippoldt A, Liebner S, Andbjer B, Kalbacher H, Wolburg H, Haller H, and Fuxe K. Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport 11: 1427-1431, 2000.
100. Liyanage M, Frith D, Livneh E, and Stabel S. Protein kinase C group B members PKC-delta, -epsilon, -zeta and PKC-L (eta). Comparison of properties of recombinant proteins in vitro and in vivo. Biochem J 283: 781-787, 1992.
101. Lopez-Ongil S, Torrecillas G, Perez-Sala D, GonzalezSantiago L, Rodriguez-Puyol M, and Rodriguez-Puyol D. Mechanisms involved in the contraction of endothelial cells by hydrogen peroxide. Free Radic Biol Med 26: 501-510, 1999.
102. Lum H. Endothelial cell activation and barrier dysfunction. In: Pulmonary Edema, edited by Weir EK and Reeves SL. Mt. Kisco, NY: Futura, 1998, p. 247-260.
103. 2+ and inositol polyphosphates. Am J Physiol Lung Cell Mol Physiol 263: L219-L225, 1992.
104. Lum H, Del Vecchio PJ, Schneider AS, Goligorski MS, and Malik AB. Calcium dependence of thrombin-induced increase in endothelial albumin permeability. J Appl Physiol 66: 1471-1476, 1989.
105. Lum H and Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 267: L223-L241, 1994.
106. Lum H, Podolski JL, Gurnack ME, Schulz IT, Huang F, and Holian O. Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 281: L546-L555, 2001.
107. Lum H and Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280: C719-C741, 2001.
108. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, and Malik AB. Increased endothelial permeability mediated by protein kinase C. J Clin Invest 85: 1991-1998, 1990.
109. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-898, 1999.
110. Malik AB. Pulmonary microembolism and lung vascular injury. Eur Respir J Suppl: 499s-506s, 1990.
111. Malik AB, Garcia JGN, Lo SK, Cooper JA, Perlman MB, and Johnson A. Mechanism of lung vascular injury. In: Acute Lung Injury: Pathogenesis of Adult Respiratory Distress Syndrome, edited by Kazemi H, Hyman AL, and Kadowitz PJ. Littleton, MA: P. S. G., 1986, p. 145-165.
112. Malik AB and Horgan MJ. Mechanisms of thrombin-induced lung vascular injury and edema. Am Rev Respir Dis 136: 467-470, 1987.
113. Malik AB and Johnson A. Role of humoral mediators in the pulmonary vascular response to pulmonary embolism. In: Pulmonary Vascular Physiology and Pathophysiology, edited by Weir EK and Reeves JT. New York: Dekker, 1988, p. 445-468.
114. Malik AB, Johnson A, and Tahamont MV. Mechanisms of lung vascular injury after intravascular coagulation. Ann NY Acad Sci 384: 213-234, 1982.
115. Malik AB, Selig WM, and Burhop KE. Cellular and humoral mediators of pulmonary edema. Lung 163: 193-219, 1985.
116. Manconi F, Markham R, and Fraser IS. Culturing endothelial cells of microvascular origin. Methods Cell Sci 22: 89-99, 2000.
117. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, and Murray JF. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141: 94-97, 1990.
118. Mason JC, Yarwood H, Sugars K, and Haskard DO. Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation. Am J Physiol Cell Physiol 273: C1233-C1240, 1997.
119. McCormick JR, Chrzanowski R, Andreani J, and Catravas JD. Early pulmonary endothelial enzyme dysfunction after phorbol ester in conscious rabbits. J Appl Physiol 63: 1972-1978, 1987.
120. Mehta D, Rahman A, and Malik AB. Protein kinase C-α signals Rho-guanine nucleotide dissociation inhibitor phosphorylation and Rho activation and regulates the endothelial cell barrier function. J Biol Chem 276: 22614-22620, 2001.
121. Minnear FL, Martin D, Hill L, Taylor AE, and Malik AB. Lung morphological and permeability changes induced by intravascular coagulation in dogs. Am J Physiol Heart Circ Physiol 253: H634-H644, 1987.
122. Miyahara T, Shibamoto T, Wang HG, Koizumi T, Honda T, Kubo K, Sekiguchi M, and Koyama S. Lecithinized superoxide dismutase attenuates phorbol myristate acetate-induced injury in isolated dog lung. Eur J Pharmacol 344: 231-924, 1998.
123. Morel NM, Petruzzo PP, Hechtman HB, and Shepro D. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation 14: 571-583, 1990.
124. Moscat J and Diaz-Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 1: 399-403, 2000.
125. Movat HZ. The inflammatory reaction. Amsterdam: Elsevier, 1985.
126. Murphy HS, Shayman JA, Till GO, Mahrougui M, Owens CB, Ryan US, and Ward PA. Superoxide responses of endothelial cells to C5a and TNF-α: divergent signal transduction pathways. Am J Physiol Lung Cell Mol Physiol 263: L51-L59, 1992.
127. Nagpala PG, Malik AB, Vuong PT, and Lum H. Protein kinase C beta 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 166: 249-255, 1996.
128. Nasdala I, Wolburg-Buchholz K, Wolburg H, Kuhn A, Ebnet K, Brachtendorf G, Samulowitz U, Kuster B, Engelhardt B, Vestweber D, and Butz S. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J Biol Chem 277: 16294-16303, 2002.
129. Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol 9: 161-167, 1997.
130. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor-promotion. Nature 308: 693-698, 1984.
131. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-613, 1992.
132. Niwa K, Inanami O, Ohta T, Ito S, Karino T, and Kuwabara M. p38 MAPK and calcium contribute to hydrogen peroxide-induced increase of permeability in vascular endothelial cells, but ERK does not. Free Radic Res 35: 519-527, 2001.
133. Ogata N, Yamamoto H, Kugiyama K, Yasue H, and Miyamoto E. Involvement of protein kinase C in superoxide anion-induced activation of nuclear factor-kappa B in human endothelial cells. Cardiovasc Res 45: 513-521, 2000.
134. Okayama N, Grisham MB, Kevil CG, Eppihimer LA, Wink DA, and Alexander JS. Effect of reactive oxygen metabolites on endothelial permeability: role of nitric oxide and iron. Microcirculation 6: 107-116, 1999.
135. Opdahl H, Nicolaysen G, and Benestad HB. Effects of zymosan-activated plasma and phorbol myristate acetate on isolated, perfused rabbit lungs. Acta Anaesthesiol Scand 31: 499-505, 1987.
136. Palmeri D, van Zante A, Huang CC, Hemmerich S, and Rosen SD. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem 275: 19139-19145, 2000.
137. Park JH, Okayama N, Gute D, Krsmanovic A, Battarbee H, and Alexander JS. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am J Physiol Cell Physiol 277: C1066-C1074, 1999.
138. Parker PJ, Coussens L, Totty N, Rhee L, Young S, Chen E, Stabel S, Waterfield MD, and Ullrich A. The complete primary structure of protein kinase C - the major phorbol ester receptor. Science 233: 853-859, 1986.
139. Parry GC and Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 15: 612-621, 1995.
140. Patterson C, Stouffer GA, Madamanchi N, and Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 88: 987-997, 2001.
141. Patterson CE and Lum H. Update on pulmonary edema: the role and regulation of endothelial barrier function. Endothelium 8: 75-105, 2001.
142. Perry M and Taylor AE. Phorbol myristate acetate-induced injury of isolated perfused rat lungs: neutrophil dependence. J Appl Physiol 65: 2164-2169, 1988.
143. Perry ML, Kayes SG, Barnard JW, and Taylor AE. Effects of phorbol myristate acetate-stimulated human leukocytes on rat lung. J Appl Physiol 68: 235-240, 1990.
144. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, and Garcia JG. Differential effect of MLC kinase in TNF-α-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280: L1168-L1178, 2001.
145. Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, and Johnson A. TNF-α induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol Lung Cell Mol Physiol 269: L551-L559, 1995.
146. Phillips PG, Lum H, Malik AB, and Tsan MF. Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin. Am J Physiol Cell Physiol 257: C562-C567, 1989.
147. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, and Harlan JM. An endothelial cell surface(s) induced in vitro by lipopolysaccharide, interleukin 1 and tumor necrosis factoralpha increases neutrophil adherence by a CDw18-dependent mechanism. J Irnrnunol 136: 4548-4553, 1986.
148. Rahman A, Anwar KN, and Malik AB. Protein kinase C-ζ mediates TNF-α-induced ICAM-1 gene transcription in endothelial cells. Am J Physiol Cell Physiol 279: C906-C914, 2000.
149. Ratcliffe MJ, Smales C, and Staddon JM. Dephosphorylation of the catenins p120 and p100 in endothelial cells in response to inflammatory stimuli. Biochern J 338: 471-478, 1999.
150. Ron D and Kazanietz MG. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 13: 1658-1676, 1999.
151. Ross D and Joyner WL. Resting distribution and stimulated translocation of protein kinase C isoforms alpha, epsilon, and zeta in response to bradykinin and TNF in human endothelial cells. Endotheliurn 5: 321-332, 1997.
152. Ryves WJ, Evans AT, Oliver AR, Parker PJ, and Evans FJ. Activation of the PKC-isotypes alpha, beta1, gamma, delta and epsilon by phorbol esters of different biological activities. FEBS Lett 288: 5-9, 1991.
153. Said SI. Environmental injury of the lung: role of humoral mediators. Fed Proc 37: 2504-2507, 1978.
154. 2+ signalling and PKCα activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol 533: 433-445, 2001.
155. Sato K and Kawashima S. Calpain function in the modulation of signal transduction molecules. Biol Chem 382: 743-751, 2001.
156. Sauer H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001.
157. Schechtman D and Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339-6347, 2001.
158. Schoonover LL, Stewart AS, and Clifton GD. Hemodynamic and cardiovascular effects of nitric oxide modulation in the therapy of septic shock. Pharmacotherapy 20: 1184-1197, 2000.
159. Segal AW. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 83: 1787-1793, 1989.
160. Serfilippi GL, Ferro TJ, and Johnson A. Activation of protein kinase C mediates altered pulmonary vasoreactivity induced by tumor necrosis factor-α. Am J Physiol Lung Cell Mol Physiol 267: L282-L290, 1994.
161. Shasby DM, Shasby SS, and Peach MJ. Granulocytes and phorbol myristate acetate increase permeability to albumin of cultured endothelial monolayers and isolated perfused lungs. Role of oxygen radicals and granulocyte adherence. Am Rev Respir Dis 127: 72-76, 1983.
162. Shea TB, Beermann ML, Griffin WR, and Leli U. Degradation of PKCα and its free catalytic subunit protein kinase M, in intact human neuroblastoma cells and under cell free conditions. FEBS Lett 350: 223-229, 1994.
163. Shizukuda Y, Helisch A, Yokota R, and Ware JA. Downregulation of protein kinase C delta activity enhances endothelial cell adaptation to hypoxia. Circulation 100: 1909-1916, 1999.
164. Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, and Malik AB. Molecular sieving characteristics of the endothelial monolayer. J Cell Physiol 132: 111-117, 1987.
165. Siflinger-Birnboim A, Goligorski MS, Del Vecchio PJ, and Malik AB. Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increases in endothelial permeability. Lab Invest 67: 24-30, 1992.
166. Siflinger-Birnboim A and Malik AB. Regulation of endothelial permeability by second messengers. New Horiz 4: 87-98, 1996.
167. Siflinger-Birnboim A and Malik AB. Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury. J Cell Physiol 155: 234-239, 1993.
168. Slater SJ, Seiz JL, Cook AC, Buzas CJ, Malinowski SA, Kershner JL, Stagliano BA, and Stubbs CD. Regulation of PKCalpha activity by C1-C2 domain interactions. J Biol Chem 277: 15277-15285, 2002.
169. Stasek JE Jr, Patterson CE, and Garcia JG. Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol 153: 62-75, 1992.
170. Stebbins EG and Mochly-Rosen D. Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. J Biol Chem 276: 29644-29650, 2001.
171. Tahamont MV and Malik AB. Granulocytes mediate the increase in pulmonary vascular permeability after thrombin embolism. J Appl Physiol 54: 1489-1496, 1983.
172. Taher MM, Garcia JGN, and Natarajan V. Hydroperoxideinduced diacylglycerol formation and protein kinase C activation in vascular endothelial cells. Arch Biochem Biophys 303: 260-266, 1993.
173. Taylor AE. Capillary fluid filtration. Circ Res 49: 557-575, 1981.
174. Tiruppathi C, Malik AB, Del Vecchio PJ, Keese CR, and Giaever I. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc Natl Acad Sci USA 89: 7919-7923, 1992.
175. Tiruppathi C, Naqvi T, Sandoval R, Mehta D, and Malik AB. Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol 281: L958-L968, 2001.
176. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta 1411: 437-455, 1999.
177. Tonnensen MD. Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. J Invest Dermatol 93: 53S-58S, 1989.
178. Tracey KJ, Lowry SF, and Cerami A. Cachectin/TNF in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 138: 1377-1379, 1988.
179. Tsukita S and Furuse M. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann NY Acad Sci 915: 129-135, 2000.
180. Van Griensven M, Stalp M, and Seekamp A. Ischemiareperfusion directly increases pulmonary endothelial permeability in vitro. Shock 11: 259-263, 1999.
181. Van Nieuw Amerongen GP, Vermeer MA, and van Hinsbergh VWM. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol 20: 127-133, 2000.
182. Van Soeren MH, Diehl-Jones WL, Maykut RJ, and Haddara WM. Pathophysiology and implications for treatment of acute respiratory distress syndrome. AACN Clin Issues 11: 179-197, 2000.
183. Vapaatalo H and Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit 7: 1075-1085, 2001.
184. Vayrynen O, Glumoff V, and Hallman M. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung. Am J Physiol Lung Cell Mol Physiol 282: L803-L810, 2002.
185. Ventura C and Maioli M. Protein kinase C control of gene expression. Crit Rev Eukaryot Gene Expr 11: 243-67, 2001.
186. Verin AD, Liu F, Bogatcheva N, Borbiev T, Hershenson MB, Wang P, and Garcia JG. Role of ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 279: L360-L370, 2000.
187. Vu TK, Hung DT, Wheaton VI, and Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
188. 2+ signaling and endothelial permeability increase. J Cell Physiol 175: 379-387, 1998.
189. Wagner MH, Sonntag J, Strauss E, and Obladen M. Complement and contact activation related to surfactant response in respiratory distress syndrome. Pediatr Res 45: 14-18, 1999.
190. Way KJ, Chou E, and King GL. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 21: 181-187, 2000.
191. Waypa GB, Morton CA, Vincent PA, Mahoney JR Jr, Johnston WK III, and Minnear FL. Oxidant-increased endothelial permeability: prevention with phosphodiesterase inhibition vs. cAMP production. J Appl Physiol 88: 835-842, 2000.
192. Welty-Wolf KE, Carraway MS, Idell S, Ortel TL, Ezban M, Piantadosi CA. Tissue factor in experimental acute lung injury. Semin Hematol 38, Suppl 12: 35-38, 2001.
193. Westel WC, Khan WA, Merchenthaler I, Rivera H, Halpern AE, Phung HM, Negro-Vilar A, and Hannun YA. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 117: 121-131, 1992.
194. Yuan Y, Meng FY, Huang Q, Hawker J, and Wu HM. Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function. Am J Physiol Heart Circ Physiol 275: H84-H93, 1998.
195. Zhao X, Alexander JS, Zhang S, Zhu Y, Sieber NJ, Aw TY, and Carden DL. Redox regulation of endothelial barrier integrity. Am J Physiol Lung Cell Mol Physiol 281: L879-L886, 2001.
196. Zhao Y and Davis HW. Hydrogen peroxide-induced cytoskeletal rearrangement in cultured pulmonary endothelial cells. J Cell Physiol 174: 370-379, 1998.
197. Zhao Y and Davis HW. Signaling pathways in thrombininduced actin reorganization in pulmonary artery endothelial cells. Exp Lung Res 25: 23-39, 1999.
198. Zhao Y, Neltner BS, and Davis HW. Role of MARCKS in regulating endothelial cell proliferation. Am J Physiol Cell Physiol 279: C1611-C1620, 2000.
199. Zimmerman GA, McIntyre TM, and Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cell in vitro. J Clin Invest 76: 2235-2246, 1985.
200. Zimmerman GA, Prescott SM, and McIntyre TM. Endothelial cell interactions with leukocytes: tethering and signaling molecules. Immunol Today 13: 93-100, 1992.
201. Zulueta JJ, Yu FS, Hertig IA, Thannickal VJ, and Hassoun PM. Release of hydrogen peroxide in response to hypoxiareoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol 12: 41-49, 1995.